Glypican-3 gene function in regulating body size helps inform novel cancer treatments
Monday, May 12, 2008 - 16:42
in Health & Medicine
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have discovered how the loss of the GPC3 gene induces overgrowth through certain growth factors such as Sonic Hedgehog which stimulate cancer growth.